Related Experiment Video
Updated: Aug 29, 2026

Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
Special aspects of renal osteodystrophy in children
Isidro B Salusky1, Beatriz G Kuizon, Harald Jüppner
1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. isalusky@mednet.ucla.edu
Insights
Chronic kidney disease (CKD) in children causes growth retardation through complex skeletal changes. Understanding these bone alterations is key to addressing pediatric growth issues in renal failure.
Area of Science:
- Pediatric Nephrology
- Skeletal Biology
- Endocrinology
Background:
- Renal osteodystrophy encompasses a range of bone diseases in chronic kidney disease (CKD) patients.
- While adults and children share pathogenesis factors, pediatric CKD uniquely involves growth retardation and bone deformities.
- Key factors include metabolic acidosis, malnutrition, and altered insulin growth factor (IGF)/growth hormone (GH) signaling.
Purpose of the Study:
- To explore the pathogenesis of renal osteodystrophy in pediatric CKD.
- To investigate the impact of CKD on growth plate cartilage and endochondral ossification.
- To identify potential molecular mechanisms underlying growth retardation in pediatric renal failure.
Main Methods:
- Review of factors contributing to renal osteodystrophy in adult and pediatric CKD.
- Analysis of growth plate characteristics in young rats with experimental CKD.
- Comparison of growth plate differences between severe secondary hyperparathyroidism and calcium-induced adynamic osteodystrophy models.
Main Results:
- Experimental CKD in young rats demonstrated growth retardation.
- Significant differences were observed in growth plate characteristics based on the type of osteodystrophy (hyperparathyroid vs. adynamic).
- These findings suggest altered endochondral bone formation in renal failure.
Conclusions:
- Pediatric CKD presents unique skeletal complications, notably growth retardation.
- The distinct growth plate pathologies in experimental models highlight the complex interplay of factors affecting bone growth.
- Further research into molecular mechanisms is warranted to understand and potentially treat growth disturbances in pediatric renal failure.
Abstract:
Renal osteodystrophy represents a spectrum of skeletal lesions that range from high-turnover to low-turnover bone disease. Similar factors are involved in the pathogenesis of renal osteodystrophy in adult and pediatric patients with chronic kidney disease (CKD). However, growth retardation and the development of bone deformities are specific complications that occurred in pediatric patients with CKD. Metabolic acidosis, renal osteodystrophy, malnutrition, and disturbances in the insulin growth factor (IGF)/growth hormone (GH) are among the main factors involved and they are discussed briefly in this article. In addition to disturbances in bone remodeling, longitudinal bone growth occurs at the growth plate cartilage by endochondral ossification. Although young rats with experimental CKD have growth retardation, the characteristics of the growth plate are markedly different between animals with severe secondary hyperparathyroidism and those with calcium-induced adynamic osteodystrophy. These disturbances may suggest potential molecular mechanisms by which endochondral bone formation may be altered in renal failure, consequently leading to growth retardation.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?
Osteoclasts in Bone Remodeling
Bone Remodeling
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
